date,title,source
Oct-22-18,DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration,GlobeNewswire
Oct-26-18,DBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers,GlobeNewswire
Oct-30-18,"DBV Technologies Reports September 30, 2018 Cash Position",GlobeNewswire
